Highlights from the report produced by the third Lancet Commission on Dementia Prevention, Intervention, and Care were presented on 31 July at the 2024 Alzheimer’s Association International Conference (AAIC). Previous commission reports in 2017 and 2020 also argued for preventive strategies that target modifiable risk factors associated with cognitive impairment. The 2024 report expands the list to 14 health factors that are potential targets for preventive measures: cardiovascular disease, especially…READ MORE

PHILADELPHIA, July 30, 2024 /PRNewswire/ -- uMethod Health, a pioneer in personalized cognitive care planning, has announced that it is collaborating with Linus Health, a digital health company enabling early detection of cognitive impairment, Alzheimer's and other dementias, to create a more efficient and effective approach to brain health. The collaboration provides clinicians with an integrated solution for earlier detection of cognitive impairment plus care planning. With the increasing prevalence of cognitive impairment, including…READ MORE

Raleigh, NC – July 8, 2024 – uMethod Health, a trailblazer in precision medicine and personalized health solutions, proudly announces the appointment of Dr. Ida Crocker-Sabbagh as its Chief Medical Officer (CMO). Dr. Crocker-Sabbagh's extensive clinical expertise and groundbreaking work in Alzheimer's disease prevention elevate uMethod Health's commitment to transforming patient care through innovative technology and personalized care plans. With a distinguished career spanning over three decades, Dr. Crocker-Sabbagh specializes…READ MORE

John Q Walker, Ph.D., the Co-founder, and Chief Technology Officer of uMethod Health, recently participated in a distinguished panel of experts in the field of disease. The discussion centered around translating technological advancements into actionable strategies at a clinical level. Together, the panel delved into the realm of proactive, precision, and holistic medicine, identifying it as the next frontier in healthcare. Dr. Walker describes how uMethod is at the forefront…READ MORE

Nearly half (48.1%) of American adults have high blood pressure (HBP, or hypertension). However, many are unaware of the problem, which often causes no symptoms. This situation is very dangerous. HBP damages the heart and blood vessels and causes strokes. It’s a leading cause of kidney failure. Hypertension is even a major risk factor for Alzheimer's disease and related dementias (ADRD). The combination of HBP and sleep apnea is particularly…READ MORE

Michael K. Racke, MD, medical director of neurology at Quest Diagnostics, delved into some commonly-believed myths about Alzheimer disease and provided his insight on the scientific explanations for these assumptions. Common myths:#1: Only older patients need to worry about AD. #2: AD is primarily an inherited genetic disease. #3: Most patients don’t want to know if they are at risk of developing AD. #4: Only high-powered imaging tests can help evaluate for AD. #5: Only…READ MORE

Cognitive decline is multi-factorial but rarely treated as such due to clinical complexity of the process. Emerging data driven systems with assistive-AI enable physicians to deliver comprehensive and personalized care at scale. Vik's session introduces uMETHOD's RestoreU solution, a software based service which is helping transform care of cognitive decline and its costs to society. The solution is available nationwide through several diagnostic lab service providers. To view Vik's discussion…READ MORE

The US Senate passed the Promise to Address Comprehensive Toxics (PACT) Act on August 2, 2022. The PACT healthcare bill is a positive step toward assisting the 3.5 million veterans affected by exposure to toxins during military service. The debate surrounding the PACT legislation drew attention to a stark fact: too many of America’s veterans live with ill health. In 2020, the Veterans Administration National Center for PTSD conducted a…READ MORE

As a part of its efforts during Alzheimer's Awareness Month, uMETHOD is educating the public on the risk factors associated with Alzheimer's and the importance of early intervention. Alzheimer's disease is a progressive brain disorder that affects 5.7 million U.S. adults, with many more in preceding stages of decline. The impacts of the disease are devastating and extend beyond memory loss. Alzheimer's and dementia can bring pain, stress, financial ruin,…READ MORE

OKLAHOMA CITY, Oct. 17, 2023 -- Tribal Diagnostics, a high-complexity diagnostics laboratory, has announced availability of the RestoreU™ Dementia Panel throughout Texas and Oklahoma. RestoreU is a risk assessment and care plan service created by uMETHOD Health, a health technology company specializing in precision medicine for chronic diseases, to help physicians close care gaps for patients with cognitive decline. RestoreU's Assistive AI improves care for individuals suffering from chronic diseases like Alzheimer's with multiple underlying medical causes. It creates…READ MORE